• Compass Therapeutics to Participate in the Leerink Partners Global Biopharma Conference

    来源: Nasdaq GlobeNewswire / 29 2月 2024 07:00:00   America/Chicago

    BOSTON, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the Leerink Partners Global Biopharma Conference in Miami Beach, Florida on Wednesday, March 13, 2024.

    Fireside Chat details
    Date: Wednesday, March 13, 2024
    Time: 10:40 AM ET
    Webcast Link: https://wsw.com/webcast/

    Virtual/Replay availability: The corporate presentation will be archived for 90 days on Compass’ Events page.

    About Compass Therapeutics
    Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. Compass’s scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. Compass’s pipeline of novel product candidates is designed to target multiple critical biological pathways required for an effective anti-tumor response. These include modulation of the microvasculature via angiogenesis-targeted agents, induction of a potent immune response via activators on effector cells in the tumor microenvironment, and alleviation of immunosuppressive mechanisms used by tumors to evade immune surveillance. Compass plans to advance its product candidates through clinical development as both standalone therapies and in combination with proprietary pipeline antibodies based on supportive clinical and nonclinical data. Compass was founded in 2014 and is headquartered in Boston, Massachusetts. For more information, visit the Compass Therapeutics, Inc. website at www.compasstherapeutics.com.

    Investor Contact
    ir@compasstherapeutics.com

    Media Contact
    Anna Gifford, Senior Manager of Communications
    media@compasstherapeutics.com
    617-500-8099


    Primary Logo

分享